Bernstein Initiates Coverage of Revolution Medicines (RVMD) with Market Perform Recommendation
23/5 02:03
Fintel reports that on May 22, 2026, Bernstein initiated coverage of Revolution Medicines (NasdaqGS:RVMD) with a Market Perform recommendation. Analyst Price Forecast Suggests 19.64% Upside...